Literature DB >> 14636921

Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy.

Lars H Lund1, Keith D Aaronson, Donna M Mancini.   

Abstract

Peak VO(2) and the Heart Failure Survival Score are 2 clinical parameters used to risk stratify patients with heart failure and time listing for cardiac transplantation. The efficacy of these prognostic variables in patients receiving beta-blocker therapy was evaluated.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14636921     DOI： 10.1016/j.amjcard.2003.08.027

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Cardiopulmonary exercise test in chronic heart failure: beyond peak oxygen consumption.

Authors:  Veronica Franco
Journal:  Curr Heart Fail Rep       Date:  2011-03

2.  Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation.

Authors:  Tomoko S Kato; Gerin R Stevens; Jeffrey Jiang; P Christian Schulze; Natalie Gukasyan; Matthew Lippel; Alison Levin; Shunichi Homma; Donna Mancini; Maryjane Farr
Journal:  J Heart Lung Transplant       Date:  2013-03       Impact factor: 10.247

3.  Deep-learning-assisted analysis of echocardiographic videos improves predictions of all-cause mortality.

Authors:  Christopher M Haggerty; Brandon K Fornwalt; Alvaro E Ulloa Cerna; Linyuan Jing; Christopher W Good; David P vanMaanen; Sushravya Raghunath; Jonathan D Suever; Christopher D Nevius; Gregory J Wehner; Dustin N Hartzel; Joseph B Leader; Amro Alsaid; Aalpen A Patel; H Lester Kirchner; John M Pfeifer; Brendan J Carry; Marios S Pattichis
Journal:  Nat Biomed Eng       Date:  2021-02-08       Impact factor: 25.671

Review 4.  Who has advanced heart failure?: definition and epidemiology.

Authors:  Omar F Abouezzeddine; Margaret M Redfield
Journal:  Congest Heart Fail       Date:  2011-07-21

5.  Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival Score.

Authors:  Jennifer Franke; Andreas Lindmark; Matthias Hochadel; Christian Zugck; Eva Koerner; Jeannette Keppler; Philipp Ehlermann; Ralph Winkler; Ralf Zahn; Hugo A Katus; Jochen Senges; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2014-11-06       Impact factor: 5.460
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.